Cryobiopsy with radial-endobronchial ultrasound (Cryo-Radial) has comparable diagnostic yield with higher safety in comparison to computed tomography-guided transthoracic biopsy for peripheral pulmonary lesions : An exploratory randomised study

© 2022 The Authors. Internal Medicine Journal published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Physicians..

BACKGROUND: Computed tomography-guided transthoracic biopsy (CT-TTB) is the 'gold standard' biopsy for lung nodules. Radial-endobronchial ultrasound (R-EBUS) bronchoscopy is another recommended biopsy but carries a lower diagnostic yield. Addition of cryobiopsy with R-EBUS (Cryo-Radial) has shown promising results. There are no studies comparing CT-TTB with Cryo-Radial biopsy.

AIM: The co-primary aims were the diagnostic yeild and safety. The secondary aim: ability to test epidermal growth factor receptor (EGFR).

METHODS: A randomised controlled, multicentre exploratory study was conducted at three tertiary hospitals. Patients with nodules >1 cm on CT of the chest were randomised to CT-TTB or Cryo-Radial. With Cryo-Radial, patients had 1-3 cryo-biopsies in addition to at least one R-EBUS biopsy through the 2.6 mm guide sheath.

RESULTS: Forty-eight patients were randomised: 22 to CT-TTB and 26 to Cryo-Radial. Sixteen in the CT-TTB and 20 in the Cryo-Radial received the allocated biopsy. The diagnostic yield was CT-TTB 93.8% (15/16) versus Cryo-Radial 85% (17/20) P = 0.61 and the odds ratio was 0.37. For 5/13 (38%), a diagnosis was solely made on cryobiopsy. Eleven (78%) of 14 in CT-TTB versus 7/10 (70%) Cryo-Radial were suitable for EGFR testing P = 0.66, with odds ratio 0.63. Pneumothorax occurrence was 44% (7/16) in CT-TTB versus 4.2% (1/24) in Cryo-Radial. Two (12.5%) of 16 CT-TTB required chest drain insertion.

CONCLUSION: Cryo-Radial is comparable in diagnostic yield and ability to perform EGFR testing with a significantly lower risk of pneumothorax, compared with CT-TTB. Cryo-Radial has the additional advantage of mediastinal staging during the same procedure with Linear-EBUS and is a promising first-line tool in the diagnostic method of lung cancer.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:53

Enthalten in:

Internal medicine journal - 53(2023), 8 vom: 01. Aug., Seite 1390-1399

Sprache:

Englisch

Beteiligte Personen:

Herath, Samantha [VerfasserIn]
Wong, Conroy [VerfasserIn]
Dawkins, Paul [VerfasserIn]
Veale, Andrew [VerfasserIn]
Yap, Elaine [VerfasserIn]
Williamson, Jonathan [VerfasserIn]
Low, Irene [VerfasserIn]
Mahajan, Hema [VerfasserIn]
Prvan, Tania [VerfasserIn]
Barnard, Stuart [VerfasserIn]
Hawkins, Stewart [VerfasserIn]
Cookson, Dan [VerfasserIn]
Singh, Tushar [VerfasserIn]
Ing, Alvin [VerfasserIn]

Links:

Volltext

Themen:

Bleeding
CT-guided biopsy
Cryo-biopsy
Diagnostic yield
EGFR
Journal Article
Multicenter Study
Radial EBUS
Randomized Controlled Trial

Anmerkungen:

Date Completed 22.08.2023

Date Revised 29.09.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1111/imj.15833

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM341969419